Immune recovery in HIV with Mycobacterium W.
J Indian Med Assoc
;
2002 Sep; 100(9): 578-9
Article
in English
| IMSEAR
| ID: sea-101342
ABSTRACT
The human immunodeficiency virus (HIV) is associated with decreased immunity. There is depletion of CD4 cells. The objective of this study was to evaluate the effect of mycobacterium w on CD4 cell count in HIV + ve patients. A total of fifty patients were randomly assigned to one of the three treatment groups (A) Mycobacterium w alone (n=17) (B) mycobacterium w plus two antiretroviral agents (n=16) (C) Mycobacterium w plus HAART (highly active antiretroviral therapy; (n=17). Mycobacterium w was administered intradermally at the dose of 0.1 ml in both deltoid region (first dose). The subsequent four doses of mycobacterium w were 0.1 intradermal in the deltoid region of one arm at monthly intervals. CD4 cell count in all the HIV + ve patients was measured at baseline and after five months period. CD4 counts was increased by 108.96%, compared to baseline, in the patients receiving both mycobacterium w and HAART, suggesting a synergistic action. However, significant increase (80.22% compared to baseline)was also seen in patients receiving mycobacterium w along, suggesting that myobacterium w was an effective immune response enhancer. Mycobacterium w was well tolerated by all patients.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Humans
/
Bacterial Vaccines
/
HIV Infections
/
Treatment Outcome
/
CD4 Lymphocyte Count
/
Antiretroviral Therapy, Highly Active
/
Immune System
Type of study:
Controlled clinical trial
Language:
English
Journal:
J Indian Med Assoc
Year:
2002
Type:
Article
Similar
MEDLINE
...
LILACS
LIS